$354.78
+1.99
(+0.56%)▲
1.01%
Downside
Day's Volatility :1.37%
Upside
0.36%
39.51%
Downside
52 Weeks Volatility :39.77%
Upside
0.43%
Period | Hca Holdings, Inc. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | 15.03% | 6.5% | 5.9% |
6 Months | 24.47% | 7.1% | 10.4% |
1 Year | 25.02% | 9.8% | 18.2% |
3 Years | 43.55% | 14.2% | 22.1% |
Market Capitalization | 90.1B |
Book Value | - $6.06 |
Dividend Share | 2.52 |
Dividend Yield | 0.77% |
Earnings Per Share (EPS) | 21.29 |
PE Ratio | 16.16 |
PEG Ratio | 1.44 |
Wall Street Target Price | 378.89 |
Profit Margin | 8.4% |
Operating Margin TTM | 15.61% |
Return On Assets TTM | 11.47% |
Return On Equity TTM | 73.61% |
Revenue TTM | 68.3B |
Revenue Per Share TTM | 257.29 |
Quarterly Revenue Growth YOY | 10.299999999999999% |
Gross Profit TTM | 23.2B |
EBITDA | 13.4B |
Diluted Eps TTM | 21.29 |
Quarterly Earnings Growth YOY | 0.29 |
EPS Estimate Current Year | 21.86 |
EPS Estimate Next Year | 24.25 |
EPS Estimate Current Quarter | 5.01 |
EPS Estimate Next Quarter | 4.88 |
What analysts predicted
Upside of 6.8%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 46.7B | ↑ 7.02% |
Net Income | 3.8B | ↑ 70.89% |
Net Profit Margin | 8.11% | ↑ 3.03% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 51.3B | ↑ 9.98% |
Net Income | 3.5B | ↓ 7.45% |
Net Profit Margin | 6.83% | ↓ 1.28% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 51.5B | ↑ 0.38% |
Net Income | 3.8B | ↑ 7.1% |
Net Profit Margin | 7.28% | ↑ 0.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 58.8B | ↑ 14.01% |
Net Income | 7.0B | ↑ 85.3% |
Net Profit Margin | 11.84% | ↑ 4.56% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 60.2B | ↑ 2.52% |
Net Income | 5.6B | ↓ 18.88% |
Net Profit Margin | 9.37% | ↓ 2.47% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 65.0B | ↑ 7.86% |
Net Income | 5.2B | ↓ 7.11% |
Net Profit Margin | 8.07% | ↓ 1.3% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 15.5B | ↑ 3.51% |
Net Income | 2.1B | ↑ 83.51% |
Net Profit Margin | 13.43% | ↑ 5.86% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 15.6B | ↑ 0.61% |
Net Income | 1.4B | ↓ 34.5% |
Net Profit Margin | 8.74% | ↓ 4.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 15.9B | ↑ 1.73% |
Net Income | 1.2B | ↓ 12.47% |
Net Profit Margin | 7.52% | ↓ 1.22% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 16.2B | ↑ 2.22% |
Net Income | 1.1B | ↓ 9.56% |
Net Profit Margin | 6.66% | ↓ 0.86% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 17.3B | ↑ 6.72% |
Net Income | 1.6B | ↑ 48.93% |
Net Profit Margin | 9.29% | ↑ 2.63% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 17.3B | ↑ 0.21% |
Net Income | 1.6B | ↓ 1.0% |
Net Profit Margin | 9.18% | ↓ 0.11% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 39.2B | ↑ 7.14% |
Total Liabilities | 42.1B | ↑ 1.29% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 45.1B | ↑ 14.92% |
Total Liabilities | 45.6B | ↑ 8.3% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 47.5B | ↑ 5.4% |
Total Liabilities | 44.6B | ↓ 2.25% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 50.7B | ↑ 6.85% |
Total Liabilities | 49.3B | ↑ 10.44% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 52.4B | ↑ 3.34% |
Total Liabilities | 52.5B | ↑ 6.61% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 56.2B | ↑ 7.2% |
Total Liabilities | 55.2B | ↑ 5.03% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 52.4B | ↑ 1.85% |
Total Liabilities | 52.5B | ↑ 0.48% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 52.7B | ↑ 0.52% |
Total Liabilities | 52.5B | ↓ 0.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 53.6B | ↑ 1.68% |
Total Liabilities | 53.1B | ↑ 1.25% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 54.6B | ↑ 1.86% |
Total Liabilities | 54.2B | ↑ 2.07% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 56.2B | ↑ 2.97% |
Total Liabilities | 55.2B | ↑ 1.69% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 57.0B | ↑ 1.34% |
Total Liabilities | 55.7B | ↑ 0.98% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.8B | ↑ 24.6% |
Investing Cash Flow | -3.9B | ↓ 8.83% |
Financing Cash Flow | -3.1B | ↑ 189.82% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.6B | ↑ 12.44% |
Investing Cash Flow | -5.7B | ↑ 46.63% |
Financing Cash Flow | -1.8B | ↓ 42.41% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.2B | ↑ 21.44% |
Investing Cash Flow | -3.4B | ↓ 40.68% |
Financing Cash Flow | -4.7B | ↑ 164.09% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.0B | ↓ 2.96% |
Investing Cash Flow | -2.6B | ↓ 22.1% |
Financing Cash Flow | -6.7B | ↑ 42.29% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.5B | ↓ 4.88% |
Investing Cash Flow | -3.4B | ↑ 28.23% |
Financing Cash Flow | -5.7B | ↓ 15.01% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.5B | ↓ 16.32% |
Investing Cash Flow | -3.4B | ↑ 520.7% |
Financing Cash Flow | -1.8B | ↓ 20.67% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.8B | ↓ 28.65% |
Investing Cash Flow | -1.2B | ↓ 66.04% |
Financing Cash Flow | -725.0M | ↓ 60.55% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.5B | ↑ 37.27% |
Investing Cash Flow | -2.4B | ↑ 109.21% |
Financing Cash Flow | -1.2B | ↑ 65.24% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.5B | ↑ 0.16% |
Investing Cash Flow | -3.7B | ↑ 54.49% |
Financing Cash Flow | -1.1B | ↓ 5.51% |
Sell
Neutral
Buy
Hca Holdings, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Hca Holdings, Inc. | 3.62% | 24.47% | 25.02% | 43.55% | 143.2% |
![]() Fresenius Medical Care Ag | 6.75% | 1.59% | -22.77% | -49.63% | -45.76% |
![]() Tenet Healthcare Corp. | 10.35% | 80.65% | 95.1% | 108.93% | 580.33% |
![]() Universal Health Services Inc. | 8.08% | 30.09% | 44.94% | 32.59% | 34.96% |
![]() Davita Healthcare Partners Inc. | 0.24% | 32.97% | 40.81% | 19.01% | 139.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Hca Holdings, Inc. | 16.16 | 16.16 | 1.44 | 21.86 | 0.74 | 0.11 | 0.01 | -6.06 |
![]() Fresenius Medical Care Ag | 22.58 | 22.58 | 0.39 | 1.5 | 0.05 | 0.03 | 0.03 | 47.4 |
![]() Tenet Healthcare Corp. | 5.46 | 5.46 | 1.74 | 8.98 | 0.54 | 0.07 | NA | 16.09 |
![]() Universal Health Services Inc. | 15.8 | 15.8 | 1.87 | 13.79 | 0.13 | 0.06 | 0.0 | 93.48 |
![]() Davita Healthcare Partners Inc. | 16.31 | 16.31 | 1.16 | 9.32 | 0.43 | 0.06 | NA | 10.56 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Hca Holdings, Inc. | Buy | $90.1B | 143.2% | 16.16 | 8.4% |
![]() Fresenius Medical Care Ag | Hold | $11.9B | -45.76% | 22.58 | 2.48% |
![]() Tenet Healthcare Corp. | Buy | $14.6B | 580.33% | 5.46 | 12.54% |
![]() Universal Health Services Inc. | Hold | $12.4B | 34.96% | 15.8 | 5.57% |
![]() Davita Healthcare Partners Inc. | Hold | $12.6B | 139.9% | 16.31 | 6.61% |
Insights on Hca Holdings, Inc.
Revenue is up for the last 8 quarters, 14.82B → 17.33B (in $), with an average increase of 2.2% per quarter
Netprofit is down for the last 2 quarters, 1.60B → 1.59B (in $), with an average decrease of 1.0% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 95.1% return, outperforming this stock by 70.1%
In the last 3 years, Tenet Healthcare Corp. has given 108.9% return, outperforming this stock by 65.3%
Vanguard Group Inc
BlackRock Inc
Wellington Management Company LLP
Sanders Capital, LLC
State Street Corporation
Arnhold & S. Bleichroeder Advisers, LLC
In the quarter ending March,2024. Hca Holdings, Inc. has declared dividend of $0.66
Read MoreHCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968.
Organization | Hca Holdings, Inc. |
Employees | 220000 |
CEO | Mr. Samuel N. Hazen |
Industry | Health Services |